1. Home
  2. PHYS vs EXAS Comparison

PHYS vs EXAS Comparison

Compare PHYS & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHYS
  • EXAS
  • Stock Information
  • Founded
  • PHYS N/A
  • EXAS 1995
  • Country
  • PHYS
  • EXAS United States
  • Employees
  • PHYS N/A
  • EXAS N/A
  • Industry
  • PHYS
  • EXAS Medical Specialities
  • Sector
  • PHYS
  • EXAS Health Care
  • Exchange
  • PHYS NYSE
  • EXAS Nasdaq
  • Market Cap
  • PHYS 11.9B
  • EXAS 9.9B
  • IPO Year
  • PHYS N/A
  • EXAS N/A
  • Fundamental
  • Price
  • PHYS $25.48
  • EXAS $52.99
  • Analyst Decision
  • PHYS
  • EXAS Strong Buy
  • Analyst Count
  • PHYS 0
  • EXAS 20
  • Target Price
  • PHYS N/A
  • EXAS $70.26
  • AVG Volume (30 Days)
  • PHYS N/A
  • EXAS 2.9M
  • Earning Date
  • PHYS N/A
  • EXAS 08-06-2025
  • Dividend Yield
  • PHYS N/A
  • EXAS N/A
  • EPS Growth
  • PHYS N/A
  • EXAS N/A
  • EPS
  • PHYS N/A
  • EXAS N/A
  • Revenue
  • PHYS N/A
  • EXAS $2,828,128,000.00
  • Revenue This Year
  • PHYS N/A
  • EXAS $14.61
  • Revenue Next Year
  • PHYS N/A
  • EXAS $12.65
  • P/E Ratio
  • PHYS N/A
  • EXAS N/A
  • Revenue Growth
  • PHYS N/A
  • EXAS 11.57
  • 52 Week Low
  • PHYS N/A
  • EXAS $39.97
  • 52 Week High
  • PHYS N/A
  • EXAS $72.83
  • Technical
  • Relative Strength Index (RSI)
  • PHYS 49.67
  • EXAS 48.51
  • Support Level
  • PHYS $25.17
  • EXAS $51.37
  • Resistance Level
  • PHYS $25.79
  • EXAS $55.90
  • Average True Range (ATR)
  • PHYS 0.21
  • EXAS 2.37
  • MACD
  • PHYS -0.02
  • EXAS -0.00
  • Stochastic Oscillator
  • PHYS 66.13
  • EXAS 39.67

About PHYS SPROTT PHYSICAL GOLD TRUST

Sprott Physical Gold Trust is a closed-end mutual fund trust. The company provides a secure, convenient and exchange-traded investment alternative for investors interested in holding physical gold bullion without the inconvenience associated with direct investment in physical gold bullion. The company invests mainly in long-term holdings of unencumbered, fully allocated, physical gold bullion and does not and will not speculate about short-term changes in gold prices.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: